Contract for the supply of live attenuated intranasal influenza vaccine

Concepts

• influenza vaccines
• influenza
• intranasal influenza vaccine
• annual seasonal influenza vaccination programme
• doses of vaccine
• sensitive information
• volume requirement
• legitimate commercial interest of the supplier
• children

Location

United Kingdom: Bedford, UK

Description

Provision for a contract for the supply of live attenuated intranasal influenza vaccine

Total Quantity or Scope

The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. The volume requirement is 3,364,470 doses of vaccine. Additional information: Value — this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.

Award Detail

Award Criteria

CPV Codes

• 33651660 - Influenza vaccines

Legal Justification

There is only one supplier with an exclusive global licence to manufacture and distribute this vaccine which is licensed and approved for use in the UK and due to the functions of the vaccine, there is no reasonable alternative or substitute, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) and (iii) of the Public Contracts Regulations 2015.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **